2023
DOI: 10.1016/j.prp.2023.154442
|View full text |Cite
|
Sign up to set email alerts
|

A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 208 publications
0
3
0
Order By: Relevance
“…Reciprocally, quercetin in combination with cisplatin and oxaliplatin could be used to overcome drug resistance in cancer cells [ 79 ]. On the other hand, quercetin increased sensitivity to cisplatin in human osteosarcoma cell line 143B by modulating the expression ratio of miR-217-Kras [ 94 ]. Also, coadministration of 2.5 μM of EGCG, genistein, and quercetin suppressed the cell proliferation of a prostate cancer cell line (CWR22Rv1) by controlling androgen receptor and NAD (P)H: quinone oxidoreductase 1 (NQO1) expression [ 93 ].…”
Section: Quercetin Particularitiesmentioning
confidence: 99%
“…Reciprocally, quercetin in combination with cisplatin and oxaliplatin could be used to overcome drug resistance in cancer cells [ 79 ]. On the other hand, quercetin increased sensitivity to cisplatin in human osteosarcoma cell line 143B by modulating the expression ratio of miR-217-Kras [ 94 ]. Also, coadministration of 2.5 μM of EGCG, genistein, and quercetin suppressed the cell proliferation of a prostate cancer cell line (CWR22Rv1) by controlling androgen receptor and NAD (P)H: quinone oxidoreductase 1 (NQO1) expression [ 93 ].…”
Section: Quercetin Particularitiesmentioning
confidence: 99%
“…Reciprocally, quercetin in combination with cisplatin and oxaliplatin could be used to overcome drug resistance in cancer cells [79]. On the other hand, quercetin increased sensitivity to cisplatin in human osteosarcoma cell line 143B by modulating the expression ratio of miR-217-Kras [94]. Also, coadministration of 2.5 µM of EGCG, genistein, and quercetin suppressed the cell proliferation of a prostate cancer cell line (CWR22Rv1) by controlling androgen receptor and NAD (P)H: quinone oxidoreductase 1 (NQO1) expression [93].…”
Section: Synergistic Effect In Other Types Of Cancermentioning
confidence: 99%

Quercetin, A Flavonoid With Great Pharmacological Capacity

Carrillo-Martinez,
Flores-Hernández,
Salazar-Montes
et al. 2024
Preprint
“…Reciprocally, Quercetin, in combination with cispla-tin and oxaliplatin, could be used to overcome drug resistance in cancer cells [79]. On the other hand, Quercetin increases sensi-tivity to cisplatin in human osteosarcoma cell line 143B by modulating the expression ratio of miR-217-Kras [94]. Also, co-administration of 2.5 μM of EGCG, genistein, and Quercetin suppressed the cell proliferation of a prostate cancer cell line (CWR22Rv1) by controlling androgen receptor and NAD (P)H: Quinone Oxidoreductase 1 (NQO1) expression [93].…”
Section: Synergistic Effect Against Leukemiamentioning
confidence: 99%